Home > Healthcare > Pharmaceuticals > Finished Drug Form > Anti-snoring Treatment Market
Anti-snoring Treatment Market size was worth USD 1 billion in 2022 and is projected to expand at an 8% CAGR from 2023-2032. Rising prevalence of sleeping disorders will accelerate industry growth.
Increasing incidences of sleeping disorders are expected to proliferate the need for anti-snoring treatment solutions. As per data published by the National Heart, Lung, & Blood Institute (NHLBI) in March 2022, between 50 million to 70 million people in the U.S. suffer from sleep disorders. Insomnia and sleeping disorders are major health concerns hampering the overall quality of life. Snoring is one of the key indications of potential health problems such as sleep apnea, certain cardiovascular diseases, and breath obstruction.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Anti-snoring Treatment Market Size in 2022: | USD 1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8% |
2032 Value Projection: | USD 2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 163 |
Tables, Charts & Figures: | 384 |
Segments covered: | Device, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
High-performance anti-snoring devices and treatments tend to be expensive, which may limit product penetration across low- and middle-income countries. Continuous positive airway pressure devices (CPAP) are conventionally used to minimize snoring. However, these devices can be costly with the highest pricing reaching USD 3,500. Moreover, these devices are often excluded from insurance policies, compelling patients to spend money out of their own pockets, affecting the adoption rate across the patient population.